CD8A and autoimmune thrombocytopenic purpura: A significant increase in CD4+/CD8+ cell ratio was seen in non-respond ITP group (1.05±0.33, P<0.05) after treatment when compared with that before treatment (0.98±0.50), but still lower than that in controls (1.56±0.29, P<0.05)(Table 4).